Rilpivirini

Rilpivirini is an antiretroviral medication used in the treatment of human immunodeficiency virus type 1 (HIV-1) infection. It belongs to a class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs). Rilpivirini works by inhibiting the activity of the reverse transcriptase enzyme, which is essential for HIV to replicate its genetic material. By blocking this enzyme, rilpivirini prevents the virus from multiplying in the body, thereby helping to reduce the viral load.

It is typically prescribed as part of a combination therapy, meaning it is taken along with other antiretroviral drugs, to achieve a more effective suppression of the virus. Rilpivirini is available in oral dosage forms and is often administered once daily. Its use is generally recommended for treatment-naive adults or adolescents who have a low baseline viral load.

Like all medications, rilpivirini can cause side effects. Common side effects may include rash, depression, insomnia, and gastrointestinal disturbances. Serious side effects, though less common, can also occur. It is important for patients to discuss their medical history and any potential risks with their healthcare provider before starting treatment with rilpivirini. Drug interactions are also a consideration, and patients should inform their doctor about all other medications they are taking. Rilpivirini is not a cure for HIV but is a vital component in managing the infection and improving the long-term health of individuals living with HIV.